首页> Urologic oncology> Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up.

Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up.

导出 LinkOut

翻译打印收藏纠错

第一作者： Dominik A,Barth

第一单位： Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.

作者： Dominik A,Barth ^[1] ; Nazanin,Sareban ^[2] ; Andrea K,Lindner ^[3] ; Louisa A J,Daller ^[1] ; Eva Maria,Matzhold ^[2] ; Georg,Hutterer ^[4] ; Maria,Smolle ^[5] ; Johannes,Mischinger ^[4] ; Jakob M,Riedl ^[1] ; Maximilian,Seles ^[4] ; Sebastian,Mannweiler ^[6] ; Thomas,Bauernhofer ^[1] ; Karl,Pummer ^[4] ; Renate,Pichler ^[3] ; Richard,Zigeuner ^[4] ; Peter,Schlenke ^[2] ; Martin,Pichler ^[7]

作者单位： Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria. ^[1] Department of Blood Group Serology and Transfusion Medicine, Medical University Graz, Austria. ^[2] Department of Urology, Medical University of Innsbruck, Austria. ^[3] Department of Urology, Medical University of Graz, Austria. ^[4] Department of Orthopedics and Trauma, Medical University of Graz, Austria. ^[5] Intitute for Pathology, Medical University of Graz, Austria. ^[6] Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria. Electronic address: martin.pichler@medunigraz.at. ^[7]

关键词 ABO Blood groups Prognosis Renal cell carcinoma Surgery